Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets

MT Newswires Live

Yesterday

Synlait Milk (NZE:SML, ASX:SM1) confirmed that global healthcare company Abbott received the Overseas Investment Office's approval to acquire its North Island assets under the Overseas Investment Act, according to a Thursday filing with the New Zealand bourse.

The sale, valued at $178 million, is expected to be completed by April 1, 2026, subject to customary consents and shareholder approval, the filing said.

These assets include the Pokeno manufacturing facility, Auckland blending and canning sites, a warehouse, associated inventory, and leasehold arrangements, per the filing.

The company's majority shareholder, with around 65% ownership, confirmed its support ahead of the annual meeting on Nov. 21, the filing added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2577314073"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577314073\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577314073?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 05:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577314073","market":"fut","top_or_hot":-1,"title":"Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SMLKF\">Synlait Milk</a> (NZE:SML, ASX:SM1) confirmed that global healthcare company Abbott received the Overseas Investment Office's approval to acquire its North Island assets under the Overseas Investment Act, according to a Thursday filing with the <a href=\"https://laohu8.com/S/NZERF\">New Zealand</a> bourse.</p><p>The sale, valued at $178 million, is expected to be completed by April 1, 2026, subject to customary consents and shareholder approval, the filing said.</p><p>These assets include the Pokeno manufacturing facility, Auckland blending and canning sites, a warehouse, associated inventory, and leasehold arrangements, per the filing.</p><p>The company's majority shareholder, with around 65% ownership, confirmed its support ahead of the annual meeting on Nov. 21, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSynlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-23 05:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SMLKF\">Synlait Milk</a> (NZE:SML, ASX:SM1) confirmed that global healthcare company Abbott received the Overseas Investment Office's approval to acquire its North Island assets under the Overseas Investment Act, according to a Thursday filing with the <a href=\"https://laohu8.com/S/NZERF\">New Zealand</a> bourse.</p><p>The sale, valued at $178 million, is expected to be completed by April 1, 2026, subject to customary consents and shareholder approval, the filing said.</p><p>These assets include the Pokeno manufacturing facility, Auckland blending and canning sites, a warehouse, associated inventory, and leasehold arrangements, per the filing.</p><p>The company's majority shareholder, with around 65% ownership, confirmed its support ahead of the annual meeting on Nov. 21, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7141","symbol_name":"包装食品与肉类","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2577314073","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577314073","pubTimestamp":1761167365,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Synlait Milk  confirmed that global healthcare company Abbott received the Overseas Investment Office's approval to acquire its North Island assets under the Overseas Investment Act, according to a Thursday filing with the New Zealand bourse.The sale, valued at $178 million, is expected to be completed by April 1, 2026, subject to customary consents and shareholder approval, the filing said.These assets include the Pokeno manufacturing facility, Auckland blending and canning sites, a warehouse, associated inventory, and leasehold arrangements, per the filing.The company's majority shareholder, with around 65% ownership, confirmed its support ahead of the annual meeting on Nov. 21, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7141":"包装食品与肉类","LU1721429402.USD":"BNP PARIBAS SMART FOOD \"C\" (USD) ACC","BK4581":"高盛持仓","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0058720904.USD":"联博国际健康护理基金A","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK8065":"包装食品与肉类","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4566":"资本集团","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK7509":"中概股","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","LU0122379950.USD":"贝莱德世界健康科学A2","SG9999002232.USD":"Allianz Global High Payout USD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK7505":"食品股","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BK4082":"医疗保健设备","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","BK4592":"伊斯兰概念","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4504":"桥水持仓","SML.NZ":"Synlait Milk Limited Ordinary Shares","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4568":"美国抗疫概念","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","SM1.AU":"SYNLAIT MILK LTD","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","ABT":"雅培","LU1721429741.USD":"BNP PARIBAS SMART FOOD \"CRH\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD"},"translate_title":"Synlait Milk确认投资监管机构批准雅培收购北岛资产","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SML.NZ":1.5,"ABT":1.5,"SM1.AU":1},"content_text":"Synlait Milk (NZE:SML, ASX:SM1) confirmed that global healthcare company Abbott received the Overseas Investment Office's approval to acquire its North Island assets under the Overseas Investment Act, according to a Thursday filing with the New Zealand bourse.The sale, valued at $178 million, is expected to be completed by April 1, 2026, subject to customary consents and shareholder approval, the filing said.These assets include the Pokeno manufacturing facility, Auckland blending and canning sites, a warehouse, associated inventory, and leasehold arrangements, per the filing.The company's majority shareholder, with around 65% ownership, confirmed its support ahead of the annual meeting on Nov. 21, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}